FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE

FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE was reported 2414 times

These side effects are most commonly reported by patients taking FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE:

# Side effect Count
0 DRUG INEFFECTIVE 81
1 CHRONIC KIDNEY DISEASE 53
2 DRUG EFFECT LESS THAN EXPECTED 34
3 RENAL FAILURE 27
4 ACUTE KIDNEY INJURY 23
5 OFF LABEL USE 22
6 GASTROOESOPHAGEAL REFLUX DISEASE 15
7 END STAGE RENAL DISEASE 14
8 EXPIRED PRODUCT ADMINISTERED 14
9 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14
10 NAUSEA 13
11 INCORRECT DOSE ADMINISTERED 12
12 DYSGEUSIA 11
13 ABDOMINAL PAIN UPPER 9
14 DIARRHOEA 9
15 PRODUCT AFTER TASTE 9
16 RENAL INJURY 9
17 CONDITION AGGRAVATED 8
18 DYSPNOEA 8
19 RENAL IMPAIRMENT 8
20 ANXIETY 7
21 DEPRESSION 7
22 HEADACHE 7
23 MALAISE 7
24 ABDOMINAL DISCOMFORT 6
25 DIZZINESS 6
26 INCORRECT PRODUCT ADMINISTRATION DURATION 6
27 REBOUND ACID HYPERSECRETION 6
28 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6
29 UNDERDOSE 6
30 VOMITING 6
31 DEATH 5
32 FATIGUE 5
33 NEPHROGENIC ANAEMIA 5
34 CHEST PAIN 4
35 CONSTIPATION 4
36 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
37 DYSPEPSIA 4
38 HYPERPARATHYROIDISM SECONDARY 4
39 HYPERSENSITIVITY 4
40 HYPERTENSION 4
41 INCORRECT DRUG ADMINISTRATION DURATION 4
42 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4
43 MIGRAINE 4
44 THERAPEUTIC PRODUCT EFFECT DELAYED 4
45 THERAPEUTIC RESPONSE UNEXPECTED 4
46 TUBULOINTERSTITIAL NEPHRITIS 4
47 ABDOMINAL DISTENSION 3
48 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 3
49 DRUG ADMINISTRATION ERROR 3
50 HOSPITALISATION 3
51 HYPERCHLORHYDRIA 3
52 ILLNESS 3
53 INSOMNIA 3
54 MATERNAL EXPOSURE DURING PREGNANCY 3
55 NEPHROPATHY 3
56 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3
57 RASH 3
58 REACTION TO SWEETENER 3
59 RENAL HAEMANGIOMA 3
60 THERAPEUTIC PRODUCT EFFECT DECREASED 3
61 THROAT IRRITATION 3
62 TOOTH FRACTURE 3
63 ARTHRALGIA 2
64 BLOOD GLUCOSE INCREASED 2
65 CHILLS 2
66 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2
67 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2
68 CORONARY ARTERY DISEASE 2
69 DECREASED APPETITE 2
70 DRUG EFFECT DECREASED 2
71 DRY MOUTH 2
72 FEELING ABNORMAL 2
73 FLATULENCE 2
74 GASTRIC CANCER 2
75 GASTROINTESTINAL DISORDER 2
76 HEART RATE INCREASED 2
77 HYPERKALAEMIA 2
78 LOSS OF CONSCIOUSNESS 2
79 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2
80 LUNG DISORDER 2
81 MUSCLE SPASMS 2
82 MYALGIA 2
83 NEOPLASM MALIGNANT 2
84 OCULAR HYPERAEMIA 2
85 ORAL DISCOMFORT 2
86 OROPHARYNGEAL PAIN 2
87 PAIN 2
88 PANCREATITIS 2
89 PRODUCT DOSE OMISSION ISSUE 2
90 PRODUCTIVE COUGH 2
91 PRURITUS 2
92 RENAL DISORDER 2
93 STRESS 2
94 TOOTH DISORDER 2
95 TREMOR 2
96 URINARY TRACT INFECTION 2
97 URTICARIA 2
98 WEIGHT DECREASED 2
99 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1
100 ADVERSE DRUG REACTION 1
101 ADVERSE EVENT 1
102 AGEUSIA 1
103 AGGRESSION 1
104 AMNESIA 1
105 APHTHOUS STOMATITIS 1
106 ASTHENIA 1
107 ASTHMA 1
108 BIPOLAR II DISORDER 1
109 BLADDER SPASM 1
110 BLOOD POTASSIUM DECREASED 1
111 BLOOD PRESSURE INCREASED 1
112 BODY HEIGHT DECREASED 1
113 BONE PAIN 1
114 BREAST CANCER 1
115 BRONCHITIS 1
116 BURNING SENSATION 1
117 CARDIAC ARREST 1
118 CARDIAC FAILURE 1
119 CARDIAC FAILURE CONGESTIVE 1
120 CARDIO-RESPIRATORY ARREST 1
121 CARDIOPULMONARY FAILURE 1
122 CEREBROVASCULAR ACCIDENT 1
123 CLOSTRIDIUM DIFFICILE INFECTION 1
124 CONFUSIONAL STATE 1
125 CONTRAINDICATED PRODUCT ADMINISTERED 1
126 CONTUSION 1
127 COUGH 1
128 COVID-19 1
129 CROHN^S DISEASE 1
130 CYSTIC FIBROSIS 1
131 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 1
132 DELUSION 1
133 DEVICE DIFFICULT TO USE 1
134 DIABETIC NEUROPATHY 1
135 DISEASE RECURRENCE 1
136 DRUG EFFECT INCOMPLETE 1
137 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
138 DRY SKIN 1
139 DYSSTASIA 1
140 EAR DISCOMFORT 1
141 ERUCTATION 1
142 ESCHERICHIA INFECTION 1
143 EXERCISE TOLERANCE DECREASED 1
144 EXTRA DOSE ADMINISTERED 1
145 EYE PAIN 1
146 EYE PRURITUS 1
147 FAECES DISCOLOURED 1
148 FALL 1
149 FEBRILE NEUTROPENIA 1
150 FEELING COLD 1
151 FLUSHING 1
152 FOOT FRACTURE 1
153 GASTRITIS 1
154 GASTROENTERITIS VIRAL 1
155 GASTROINTESTINAL HAEMORRHAGE 1
156 GENERALISED ANXIETY DISORDER 1
157 HALLUCINATION 1
158 HALLUCINATION, VISUAL 1
159 HERNIA 1
160 HYPOAESTHESIA 1
161 ILEUS 1
162 ILL-DEFINED DISORDER 1
163 INABILITY TO AFFORD MEDICATION 1
164 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1
165 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
166 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
167 INFLUENZA LIKE ILLNESS 1
168 INJECTION SITE BRUISING 1
169 INJECTION SITE PAIN 1
170 INTENTIONAL PRODUCT MISUSE 1
171 JAW FRACTURE 1
172 JOINT STIFFNESS 1
173 JOINT SWELLING 1
174 KNEE ARTHROPLASTY 1
175 LABORATORY TEST ABNORMAL 1
176 LARYNGOSPASM 1
177 LOSS OF BLADDER SENSATION 1
178 MAJOR DEPRESSION 1
179 MALABSORPTION 1
180 MANIA 1
181 MEMORY IMPAIRMENT 1
182 MOOD SWINGS 1
183 MULTI-ORGAN DISORDER 1
184 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
185 MULTIPLE SCLEROSIS RELAPSE 1
186 MUSCULOSKELETAL DISCOMFORT 1
187 NASAL CONGESTION 1
188 NASAL INFLAMMATION 1
189 NEPHRITIS 1
190 NERVOUSNESS 1
191 OESOPHAGEAL MUCOSA ERYTHEMA 1
192 ORAL MUCOSAL BLISTERING 1
193 ORAL PAIN 1
194 OROPHARYNGEAL DISCOMFORT 1
195 OSTEOMYELITIS 1
196 PAIN IN EXTREMITY 1
197 PALPITATIONS 1
198 PARANOIA 1
199 PARKINSON^S DISEASE 1
200 PERIPHERAL SWELLING 1
201 PHLEBITIS 1
202 PHOTOPHOBIA 1
203 PLATELET COUNT DECREASED 1
204 PNEUMONIA 1
205 POOR QUALITY SLEEP 1
206 PRODUCT COMPLAINT 1
207 PRODUCT LABEL ISSUE 1
208 PRODUCT PACKAGING ISSUE 1
209 PRODUCT SIZE ISSUE 1
210 PRODUCT SUBSTITUTION ISSUE 1
211 PRODUCT USE IN UNAPPROVED INDICATION 1
212 PSYCHOMOTOR HYPERACTIVITY 1
213 PYREXIA 1
214 RASH PRURITIC 1
215 REACTION TO EXCIPIENT 1
216 REBOUND EFFECT 1
217 RECTAL HAEMORRHAGE 1
218 RENAL CANCER 1
219 RENAL INFARCT 1
220 RENAL TUBULAR ACIDOSIS 1
221 RENAL TUBULAR NECROSIS 1
222 RESTLESSNESS 1
223 RETCHING 1
224 SCOLIOSIS 1
225 SINUSITIS 1
226 SKIN REACTION 1
227 SKIN TIGHTNESS 1
228 SLEEP DISORDER 1
229 SOCIAL PROBLEM 1
230 SOMNOLENCE 1
231 SPHINCTER OF ODDI DYSFUNCTION 1
232 SUICIDAL IDEATION 1
233 SWELLING 1
234 SWOLLEN TONGUE 1
235 THROAT TIGHTNESS 1
236 TOE AMPUTATION 1
237 TOOTHACHE 1
238 TYPE 2 DIABETES MELLITUS 1
239 UNEVALUABLE EVENT 1
240 UPPER RESPIRATORY TRACT CONGESTION 1
241 UPPER-AIRWAY COUGH SYNDROME 1
242 WEIGHT ABNORMAL 1
243 WHEEZING 1
244 WHITE BLOOD CELL COUNT DECREASED 1
245 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1